208 related articles for article (PubMed ID: 32175818)
21. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome.
Pagnamenta AT; Kaisaki PJ; Bennett F; Burkitt-Wright E; Martin HC; Ferla MP; Taylor JM; Gompertz L; Lahiri N; Tatton-Brown K; Newbury-Ecob R; Henderson A; Joss S; Weber A; Carmichael J; Turnpenny PD; McKee S; Forzano F; Ashraf T; Bradbury K; Shears D; Kini U; de Burca A; ; Blair E; Taylor JC; Stewart H
Clin Genet; 2019 Jun; 95(6):693-703. PubMed ID: 30859559
[TBL] [Abstract][Full Text] [Related]
22. LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases.
Abe T; Umeki I; Kanno SI; Inoue SI; Niihori T; Aoki Y
Cell Death Differ; 2020 Mar; 27(3):1023-1035. PubMed ID: 31337872
[TBL] [Abstract][Full Text] [Related]
23. LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.
Farncombe KM; Thain E; Barnett-Tapia C; Sadeghian H; Kim RH
BMC Med Genomics; 2022 Jul; 15(1):160. PubMed ID: 35840934
[TBL] [Abstract][Full Text] [Related]
24. A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review.
Zhao X; Li Z; Wang L; Lan Z; Lin F; Zhang W; Su Z
BMC Endocr Disord; 2021 Jan; 21(1):2. PubMed ID: 33407364
[TBL] [Abstract][Full Text] [Related]
25. Oligo-astrocytoma in LZTR1-related Noonan syndrome.
Jacquinet A; Bonnard A; Capri Y; Martin D; Sadzot B; Bianchi E; Servais L; Sacré JP; Cavé H; Verloes A
Eur J Med Genet; 2020 Jan; 63(1):103617. PubMed ID: 30664951
[TBL] [Abstract][Full Text] [Related]
26. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
Yamamoto GL; Aguena M; Gos M; Hung C; Pilch J; Fahiminiya S; Abramowicz A; Cristian I; Buscarilli M; Naslavsky MS; Malaquias AC; Zatz M; Bodamer O; Majewski J; Jorge AA; Pereira AC; Kim CA; Passos-Bueno MR; Bertola DR
J Med Genet; 2015 Jun; 52(6):413-21. PubMed ID: 25795793
[TBL] [Abstract][Full Text] [Related]
27. ESCRT-0 protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is targeted to endosomes independently of signal-transducing adaptor molecule (STAM) and the complex formation with STAM promotes its endosomal dissociation.
Kojima K; Amano Y; Yoshino K; Tanaka N; Sugamura K; Takeshita T
J Biol Chem; 2014 Nov; 289(48):33296-310. PubMed ID: 25296754
[TBL] [Abstract][Full Text] [Related]
28. Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.
Kanugula AK; Adapala RK; Midha P; Cappelli HC; Meszaros JG; Paruchuri S; Chilian WM; Thodeti CK
FASEB J; 2019 Jan; 33(1):195-203. PubMed ID: 29957061
[TBL] [Abstract][Full Text] [Related]
29. Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8·STAM complex.
Berlin I; Schwartz H; Nash PD
J Biol Chem; 2010 Nov; 285(45):34909-21. PubMed ID: 20736164
[TBL] [Abstract][Full Text] [Related]
30. The ubiquitin ligase UBE4B regulates amyloid precursor protein ubiquitination, endosomal trafficking, and amyloid β42 generation and secretion.
Gireud-Goss M; Reyes S; Tewari R; Patrizz A; Howe MD; Kofler J; Waxham MN; McCullough LD; Bean AJ
Mol Cell Neurosci; 2020 Oct; 108():103542. PubMed ID: 32841720
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor-regulated tyrosine kinase substrate is essential for endothelial cell polarity and cerebrovascular stability.
Yu Z; Zeng J; Wang J; Cui Y; Song X; Zhang Y; Cheng X; Hou N; Teng Y; Lan Y; Chen Y; Yang X
Cardiovasc Res; 2021 Jan; 117(2):533-546. PubMed ID: 32044971
[TBL] [Abstract][Full Text] [Related]
32. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
33. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
34. Genetic Basis and Therapies for Vascular Anomalies.
Queisser A; Seront E; Boon LM; Vikkula M
Circ Res; 2021 Jun; 129(1):155-173. PubMed ID: 34166070
[TBL] [Abstract][Full Text] [Related]
35. Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.
Pasula S; Cai X; Dong Y; Messa M; McManus J; Chang B; Liu X; Zhu H; Mansat RS; Yoon SJ; Hahn S; Keeling J; Saunders D; Ko G; Knight J; Newton G; Luscinskas F; Sun X; Towner R; Lupu F; Xia L; Cremona O; De Camilli P; Min W; Chen H
J Clin Invest; 2012 Dec; 122(12):4424-38. PubMed ID: 23187125
[TBL] [Abstract][Full Text] [Related]
36. The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2.
Ash D; Sudhahar V; Youn SW; Okur MN; Das A; O'Bryan JP; McMenamin M; Hou Y; Kaplan JH; Fukai T; Ushio-Fukai M
Nat Commun; 2021 May; 12(1):3091. PubMed ID: 34035268
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein.
Li W; Zhu H; Zhao X; Brancho D; Liang Y; Zou Y; Bennett C; Chow CW
Mol Cell Biol; 2015 Jul; 35(14):2464-78. PubMed ID: 25963657
[TBL] [Abstract][Full Text] [Related]
38. Parvins Are Required for Endothelial Cell-Cell Junctions and Cell Polarity During Embryonic Blood Vessel Formation.
Pitter B; Werner AC; Montanez E
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1147-1158. PubMed ID: 29567677
[TBL] [Abstract][Full Text] [Related]
39. Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs.
Cuevas-Navarro A; Rodriguez-Muñoz L; Grego-Bessa J; Cheng A; Rauen KA; Urisman A; McCormick F; Jimenez G; Castel P
Elife; 2022 Apr; 11():. PubMed ID: 35467524
[TBL] [Abstract][Full Text] [Related]
40. UBE4B protein couples ubiquitination and sorting machineries to enable epidermal growth factor receptor (EGFR) degradation.
Sirisaengtaksin N; Gireud M; Yan Q; Kubota Y; Meza D; Waymire JC; Zage PE; Bean AJ
J Biol Chem; 2014 Jan; 289(5):3026-39. PubMed ID: 24344129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
